Kalvista Pharmaceuticals, Inc. (KALV) SEC Filings — 2024

Filings

• KalVista Pharmaceuticals Files 8-K with Board and Compensation Updates — 8-K · Dec 16, 2024
• KalVista Pharmaceuticals Files 8-K — 8-K · Dec 5, 2024
• KalVista Pharma Appoints New CMO, Director — 8-K · Nov 26, 2024
• Kalvista Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Kalvista Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Kalvista Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Nov 14, 2024
• Kalvista Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Nov 13, 2024
• Kalvista Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Kalvista Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Frazier Life Sciences Adjusts KalVista Stake to 19.9% — SC 13D/A · Nov 7, 2024
• KalVista Pharmaceuticals Files 8-K — 8-K · Nov 4, 2024
• Kalvista Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
• KalVista Pharmaceuticals Files 8-K on Shareholder Votes — 8-K · Oct 4, 2024
• KalVista Pharmaceuticals Announces Executive and Board Changes — 8-K · Sep 10, 2024
• KalVista Pharmaceuticals Files 10-Q for July 31, 2024 — 10-Q · Sep 5, 2024
• KalVista Pharma Files Definitive Proxy Statement — DEF 14A · Aug 22, 2024
• KalVista Pharma Secures $75M Loan Facility — 8-K · Jul 23, 2024
• KalVista Pharma Files 2024 10-K — 10-K · Jul 11, 2024
• KalVista Pharma Appoints New CMO, Elects Director — 8-K · Apr 22, 2024
• TCG Crossover Fund & Chen Yu Amend KalVista Stake — SC 13D/A · Apr 1, 2024
• KalVista Pharmaceuticals, Inc. Files 10-Q for Period Ending January 31, 2024 — 10-Q · Mar 11, 2024
• KalVista Pharma Appoints New CMO, Director — 8-K · Mar 7, 2024
• Kalvista Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Feb 26, 2024
• Frazier Life Sciences Updates KalVista Pharma Holdings — SC 13D/A · Feb 22, 2024
• TCG Crossover Amends KalVista Pharmaceuticals Stake — SC 13D/A · Feb 20, 2024
• KalVista Pharmaceuticals Reports Material Agreement and Financials — 8-K · Feb 16, 2024
• Kalvista Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• KalVista Pharmaceuticals Terminates Material Agreement — 8-K · Feb 14, 2024
• Kalvista Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• KalVista Pharmaceuticals Files 8-K on Feb 13, 2024 — 8-K · Feb 13, 2024
• Kalvista Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Feb 13, 2024
• Kalvista Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Saturn V Capital Takes 5.1% Stake in KalVista Pharma — SC 13G · Feb 12, 2024
• FMR LLC & Abigail Johnson Slash KalVista Stake to 0.147% — SC 13G/A · Feb 9, 2024
• BlackRock Discloses Passive Stake in KalVista Pharma — SC 13G · Jan 29, 2024